Ian Sheffield

Director/Board Member at FRACTYL HEALTH, INC.

Net worth: 23 975 $ as of 31/07/2026

49 year

98 connections

Finance

Health Technology

Consumer Services

Profile

Ian D.
Sheffield is currently an Independent Director at Fractyl Health, Inc. since 2025.
Former positions include Independent Director at Apyx Medical Corp.
from 2013 to 2015, Investment Professional at Versant Venture Management LLC, Principal at Great Point Partners Private Equity, and Analyst at Ashler Capital LLC from 2020 to 2023.
Education includes an undergraduate degree from the University of Miami in 1998 and an MBA from Harvard Business School in 2004.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
FRACTYL HEALTH, INC. 0.02%	10/06/2026	35,000 ( 0.02% )	23 975 $	31/07/2026

Ian Sheffield active positions

Companies	Position	Start
FRACTYL HEALTH, INC.	Director/Board Member	02/09/2025

All active positions of Ian Sheffield

Former positions of Ian Sheffield

Companies	Position	End
Ashler Capital LLC Ashler Capital LLC Investment ManagersFinance Ashler Capital is a value-oriented, market-neutral equity business that combines a fundamental investment approach and strong relationships with management teams in an effort to achieve consistently high risk-adjusted returns through investments in undervalued public companies. The firm employs fundamental research and financial analysis through a sector-focused approach. The portfolio management teams combines deep industry knowledge and a rigorous investment process to formulate a differentiated view of the performance of companies. Ashler Capital also identifies investments where there is an opportunity to engage with management teams pursuing opportunities to improve operating performance and strategic focus. Their sector focus are Healthcare, Industrials, Energy, Technology, Media & Telecom, Consumer, Financials, and Risk Arbitrage.	Analyst-Equity	01/12/2023
APYX MEDICAL CORPORATION	Director/Board Member	06/05/2015
Great Point Partners Private Equity Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor.	Private Equity Investor	-
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Private Equity Analyst	14/01/2011

See the detail of Ian Sheffield's experience

Training of Ian Sheffield

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian Sheffield's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Apyx Medical Corp. Apyx Medical Corp. Medical SpecialtiesHealth Technology Manufactures and markets a variety of electrosurgical medical products	Health Technology
University of Miami University of Miami Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Finance
Great Point Partners Private Equity Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor.	Finance
Fractyl Health, Inc. Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity	Health Technology
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ashler Capital LLC Ashler Capital LLC Investment ManagersFinance Ashler Capital is a value-oriented, market-neutral equity business that combines a fundamental investment approach and strong relationships with management teams in an effort to achieve consistently high risk-adjusted returns through investments in undervalued public companies. The firm employs fundamental research and financial analysis through a sector-focused approach. The portfolio management teams combines deep industry knowledge and a rigorous investment process to formulate a differentiated view of the performance of companies. Ashler Capital also identifies investments where there is an opportunity to engage with management teams pursuing opportunities to improve operating performance and strategic focus. Their sector focus are Healthcare, Industrials, Energy, Technology, Media & Telecom, Consumer, Financials, and Risk Arbitrage.	Finance